Gemeinsame Anstrengung: Das antifungisch wirkende Icumazol A und der Kaliumkanalblocker Noricumazol A sowie ihre glycosylierten Derivate sind neue, strukturell verwandte Sekundärmetabolite aus Sorangium cellulosum. Ihre Strukturen wurden durch eine Kombination aus spektroskopischen Methoden, Derivatisierungen, Fragmentierungen und schließlich der Totalsynthese von Noricumazol A aufgeklärt.
The total synthesis of 16 new ion channel inhibitors derived from noricumazole A, a secondary metabolite from the myxobacterium Sorangium cellulosum, is reported. Particular focus of library design is put on stereochemical permutations in the central region (C9 and C11), the oxazole moiety and the side chain at C4 of the isochromanone moiety. Noricumazole A and all new noricumazole derivatives were tested in an assay system with inhibitory effect on the hepatitis C virus (HCV) life cycle. Most of them are moderate to strong HCV inhibitors (350 nM-6 nM) but also exert pronounced cytotoxicity. In contrast, the thiazole analogue of noricumazole A is a strong HCV inhibitor with only moderate cytotoxic property. It may become a lead structure with a good therapeutic index (CC(50)/IC(50)) of greater than 10.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.